Literature DB >> 25701953

Long-Term Efficacy of Arthroscopic Debridement on Knee Osteoarthritis in Patients with Kashin-Beck Disease.

Ming Ling1, Zhengming Sun2, Zhi Yi2, Yanhai Chang2, Shizhang Liu2, Guang Yang3, Xin Tian2, Xianghui Dong2.   

Abstract

Kashin-Beck Disease (KBD) is a chronic and degenerative joint disease with decreased health conditions causing major functional limitations and disability. In this study, we investigated the long-term clinical outcomes of arthroscopic debridement for knee osteoarthritis in KBD patients with Kellgren-Lawrence I-III classification. 31 KBD patients underwent arthroscopic debridement and 24 of them were followed up 8 years after the surgery. The Lysholm scores, femorotibial angle (FTA), and joint space angle (JSA) of the knees were assessed and compared preoperatively and postoperatively to evaluate the clinic outcome. Our results showed that the Lysholm scores, but not the FTA or JSA, of these patients were significantly improved 8 years after the therapy, suggesting that arthroscopic surgery has long-term efficacy in KBD patients with Kellgren-Lawrence I-III classification.

Entities:  

Keywords:  Arthroscopic debridement; Kashin–Beck disease; Kellgren–Lawrence classification; Knee osteoarthritis; Lysholm scores

Mesh:

Year:  2015        PMID: 25701953     DOI: 10.1007/s12013-015-0635-3

Source DB:  PubMed          Journal:  Cell Biochem Biophys        ISSN: 1085-9195            Impact factor:   2.194


  2 in total

Review 1.  [Osteoarthritis classifications : Modification proposal for the criteria of Kellgren and Vallotton].

Authors:  R Braunschweig; G Spahn; M Regier; M-A Weber
Journal:  Radiologe       Date:  2019-11       Impact factor: 0.635

2.  Reliability and validation of the joint dysfunction index as a new assessment instrument for therapeutic efficacy for Kashin-Beck disease.

Authors:  Fang-Fang Yu; Chuan-Tao Xia; Hua Fang; Di-Miao Wang; Xiong Guo
Journal:  Clin Rheumatol       Date:  2016-04-19       Impact factor: 2.980

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.